The concentration operation in question consists of the acquisition by Oxy Capital – SGOIC, S.A. (“Oxy Capital”) and Manuel Cruz Rodrigues da Silva (“Manuel Silva”) of the joint control of A2Brios – Produção e Comércio de Soluções Químicas, Lda. (“A2Brios”), through the acquisition of the respective shareholdings representing the share capital and voting rights.